Group | Time to intervention | Pregabalin | N-acetylcysteine | P-value | |
---|---|---|---|---|---|
Variable | |||||
Mean pain score | Before | 6.9±1.8 | 6.3±1.85 | 0.36 | |
fourth week | 5.0±1.1 | 4.0±1.5 | 0.43 | ||
Eighth week | 2.3±1.4 | 1.5±1.5 |  | ||
P- value | <0.001 | <0.001 | Â | ||
Mean sleep score | Before | 4.82±2.2 | 6.11±2.2 | 0.43 | |
fourth week | 6.9±1.9 | 8.0±1.2 | 0.95 | ||
Eighth week | 9.42±0.7 | 9.7±0.5 |  | ||
P- value | <0.001 | <0.001 | Â | ||
PGIC (%) | 1 | - | 40 | 42 | - |
2 | - | 38 | 37 | - | |
3 | - | 20 | 20 | - | |
4 | - | 2 | 1 | - | |
5 | - | 0 | 0 | - | |
CGIC (%) | 1 | - | 41 | 43 | - |
2 | - | 38 | 39 | - | |
3 | - | 19 | 17 | - | |
4 | - | 2 | 1 | - | |
5 | - | 0 | 0 | - | |
Side effects (N (%)) | |||||
 Drowsiness | After | 11 (21.6) | 0 |  | |
 Nausea | 3 (6) | 8 (15.7) | 0.001 | ||
 Dyspepsia | 1 (2) | 5 (9.8) |  | ||
 No side effects | 28 (54.9) | 38 (74.5) |  |